SmaBio Labs is headed to DCAT 2026!

SmaBio Labs is headed to DCAT 2026! 🔗 Click to book a meeting with our experts: https://lnkd.in/gT8w2h5AMolecule of the Month: GabapentinFrom managing refractory epilepsy in companion animals to setting new welfare standards in bovine medicine, Gabapentin remains an essential benchmark for the industry.Why it’s a CDMO priority in 2026:✅ Precision Mechanism: Beyond its GABA-analog origins, its unique calcium channel binding offers a sophisticated approach to chronic and neuropathic pain.✅ High Bioavailability: Recent 2024–2025 data confirms oral formulations achieve near 90-100% bioavailability in key species.✅ Expanding Frontiers: New 2026 research highlights its critical role in pre-emptive analgesia for food-producing animals.How is this 50-year-old molecule shaping the future of veterinary welfare and formulation stability?🔗 Click to read our full technical briefing on the evolution of Gabapentin👇